{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:08:05Z","timestamp":1792084085363,"version":"4.4.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1038\/ajg.2010.124","type":"journal-article","created":{"date-parts":[[2010,3,30]],"date-time":"2010-03-30T10:47:19Z","timestamp":1269946039000},"page":"1986-1993","source":"Crossref","is-referenced-by-count":125,"title":["Isotretinoin Use and the Risk of Inflammatory Bowel Disease: A Case\u2013Control Study"],"prefix":"10.14309","volume":"105","author":[{"given":"Seth D","family":"Crockett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol Q","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher F","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S","family":"Sandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D","family":"Kappelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210210","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1067\/mjd.2002.120529","article-title":"Use of isotretinoin (Accutane) in the United States: rapid increase from 1992 through 2000.","volume":"46","author":"Wysowski","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R2-14-20210210","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1001\/jama.1984.03340480049027","article-title":"The isotretinoin teratogen syndrome.","volume":"251","author":"Benke","year":"1984","journal-title":"JAMA"},{"key":"R3-14-20210210","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJM198510033131401","article-title":"Retinoic acid embryopathy.","volume":"313","author":"Lammer","year":"1985","journal-title":"N Engl J Med"},{"key":"R4-14-20210210","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0140-6736(83)90538-X","article-title":"Teratogenicity of isotretinoin.","volume":"2","author":"Rosa","year":"1983","journal-title":"Lancet"},{"key":"R5-14-20210210","doi-asserted-by":"crossref","first-page":"S394","DOI":"10.14309\/00000434-200609001-00997","article-title":"Isoretinoin-associated ulcerative colitis.","volume":"101","author":"Ahmed","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R6-14-20210210","first-page":"171","article-title":"Ulcerative colitis probably associated with isotretinoin.","volume":"25","author":"Bankar","year":"2006","journal-title":"Indian J Gastroenterol"},{"key":"R7-14-20210210","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4321\/S1137-66272004000300009","article-title":"Isotretinoin and ulcerous colitis.","volume":"27","author":"Borobio","year":"2004","journal-title":"An Sist Sanit Navar"},{"key":"R8-14-20210210","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0399-8320(05)82233-X","article-title":"Ulcerative colitis probably induced by isotretinoin.","volume":"29","author":"Mennecier","year":"2005","journal-title":"Gastroenterologie Clinique Et Biologique"},{"key":"R9-14-20210210","first-page":"52","article-title":"Isotretinoin-induced inflammatory bowel disease.","volume":"64","author":"Passier","year":"2006","journal-title":"Neth J Med"},{"key":"R10-14-20210210","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1345\/aph.10368","article-title":"Isotretinoin-induced inflammatory bowel disease in an adolescent.","volume":"35","author":"Reniers","year":"2001","journal-title":"Ann Pharmacother"},{"key":"R11-14-20210210","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/j.1572-0241.2007.01158.x","article-title":"Isotretinoin and inflammatory bowel disease.","volume":"102","author":"Rolanda","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R15-14-20210210","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/j.1572-0241.2006.00632.x","article-title":"Possible association between isotretinoin and inflammatory bowel disease.","volume":"101","author":"Reddy","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R16-14-20210210","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/gut.2008.170530","article-title":"Isotretinoin and intestinal inflammation: what gastroenterologists need to know.","volume":"58","author":"Shale","year":"2009","journal-title":"Gut"},{"key":"R17-14-20210210","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1038\/ajg.2009.334","article-title":"A causal association between Accutane and IBD has yet to be established.","volume":"104","author":"Crockett","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R18-14-20210210","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1038\/ajg.2009.417","article-title":"Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study.","volume":"104","author":"Bernstein","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R19-14-20210210","doi-asserted-by":"crossref","first-page":"352","DOI":"10.18553\/jmcp.2008.14.4.352","article-title":"Administrative claims analysis of all-cause annual costs of care and resource utilization by age category for ulcerative colitis patients.","volume":"14","author":"Bickston","year":"2008","journal-title":"J Manag Care Pharm"},{"key":"R20-14-20210210","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/ibd.20530","article-title":"Effects of fistula on healthcare costs and utilization for patients with Crohns disease treated in a managed care environment.","volume":"14","author":"Cohen","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"R21-14-20210210","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/01.mjt.0000245223.43783.45","article-title":"Infliximab drug and infusion costs among patients with Crohns disease in a commercially-insured setting.","volume":"13","author":"Ollendorf","year":"2006","journal-title":"Am J Ther"},{"key":"R22-14-20210210","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cgh.2008.10.007","article-title":"Suboptimal rates of cervical testing among women with inflammatory bowel disease.","volume":"7","author":"Long","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R23-14-20210210","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.cgh.2007.07.012","article-title":"The prevalence and geographic distribution of Crohns disease and ulcerative colitis in the United States.","volume":"5","author":"Kappelman","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R24-14-20210210","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1053\/j.gastro.2008.09.012","article-title":"Direct health care costs of Crohns disease and ulcerative colitis in US children and adults.","volume":"135","author":"Kappelman","year":"2008","journal-title":"Gastroenterology"},{"key":"R25-14-20210210","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/rmed.2000.1027","article-title":"Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast.","volume":"95","author":"Stempel","year":"2001","journal-title":"Respir Med"},{"key":"R26-14-20210210","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00228-006-0151-x","article-title":"Patterns and utilization of isotretinoin for acne from 1984 to 2003: is there need for concern?","volume":"62","author":"Azoulay","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"R27-14-20210210","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1067\/mjd.2000.110901","article-title":"Medication and medical service utilization for acne 1995-1998.","volume":"43","author":"Stern","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"R28-14-20210210","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1111\/j.1572-0241.2008.01960.x","article-title":"Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996-2002.","volume":"103","author":"Herrinton","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R29-14-20210210","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1365-4362.1996.tb00647.x","article-title":"Pyoderma faciale: manifestation of inflammatory bowel disease.","volume":"35","author":"Dessoukey","year":"1996","journal-title":"Int J Dermatol"},{"key":"R30-14-20210210","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/00015550152384290","article-title":"Pyodermatitis-pyostomatitis vegetans: a clinical course of two decades with response to cyclosporine and low-dose prednisolone.","volume":"81","author":"Brinkmeier","year":"2001","journal-title":"Acta Derm Venereol"},{"key":"R31-14-20210210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1056\/NEJM199507133330206","article-title":"A pregnancy-prevention program in women of childbearing age receiving isotretinoin.","volume":"333","author":"Mitchell","year":"1995","journal-title":"N Engl J Med"},{"key":"R32-14-20210210","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jadohealth.2004.08.024","article-title":"US adolescents receive suboptimal preventive counseling during ambulatory care.","volume":"36","author":"Ma","year":"2005","journal-title":"J Adolesc Health"},{"key":"R34-14-20210210","first-page":"295","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc R Soc Med"},{"key":"R35-14-20210210","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJM200103153441104","article-title":"Appendectomy and protection against ulcerative colitis.","volume":"344","author":"Andersson","year":"2001","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"R36-14-20210210","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.MIB.0000195385.19268.68","article-title":"Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities.","volume":"12","author":"Hanauer","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"R37-14-20210210","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jaad.2005.11.1061","article-title":"Low-dose isotretinoin in the treatment of acne vulgaris.","volume":"54","author":"Amichai","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R38-14-20210210","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(80)92273-4","article-title":"13-cis retinoic acid and acne.","volume":"2","author":"Jones","year":"1980","journal-title":"Lancet"},{"key":"R39-14-20210210","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/j.1572-0241.2006.00603.x","article-title":"The epidemiology of inflammatory bowel disease in Canada: a population-based study.","volume":"101","author":"Bernstein","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R40-14-20210210","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/ibd.20021","article-title":"Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings.","volume":"13","author":"Herrinton","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"R41-14-20210210","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/gut.2003.025239","article-title":"Antibiotic use and the development of Crohns disease.","volume":"53","author":"Card","year":"2004","journal-title":"Gut"},{"key":"R42-14-20210210","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/00365520801971736","article-title":"Early-life exposures associated with antibiotic use and risk of subsequent Crohns disease.","volume":"43","author":"Hildebrand","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"R43-14-20210210","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3109\/00365528708991950","article-title":"Childhood factors in ulcerative colitis and Crohns disease. An international cooperative study.","volume":"22","author":"Gilat","year":"1987","journal-title":"Scand J Gastroenterol"},{"key":"R44-14-20210210","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1038\/ajg.2009.284","article-title":"Inflammatory bowel disease and acne.","volume":"104","author":"Murphy","year":"2009","journal-title":"Am J Gastroenterol"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2010124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2010124","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2010124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201009000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:33:58Z","timestamp":1786541638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201009000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2010.124","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}